IPOPLUS

867.1

+15.6 +1.83%

18 Jun 2026

NSE Listed · Pharmaceuticals

Natco Pharma Ltd. (NATCOPHARM)

Volume: 20,856Avg Vol 1W: 55,141Avg Vol 1M: 86,50952W Range:7891,226.8
₹867.1 1.83%
Market Cap₹15,472 Cr
Current Price₹867.1
Previous Close₹851.5
High / Low (52w)₹1,226.8 / ₹789
Volume20,856
Avg Vol (1W)55,141
Avg Vol (1M)86,509
Stock P/E7.57
Book Value₹515.15
Dividend Yield0.58%
ROE15.38%
ROA12.39%
Revenue (TTM)
Revenue Growth10.77%
Profit Margin34.78%
Total Debt₹0 Cr
Shares Outstanding18 Cr
Face Value₹2
EPS (TTM)₹14.96
P/B1.65
Debt / Equity0.08
50 DMA₹1,074.75
200 DMA₹970.12
Day change+1.83%
Price Chart
867.1 7.58% · 1Y
12097932.3Cr
2025-10-01
2026-06-16

20-day avg volume: 91K shares

Pros
  • Healthy return on equity of 15.4%.
  • Company is almost debt-free.
  • Revenue grew 16% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹739 Cr₹647 Cr₹1,363 Cr₹1,329 Cr₹1,221 Cr₹475 Cr₹1,371 Cr₹1,363 Cr₹1,068 Cr₹759 Cr₹1,031 Cr₹1,141 Cr₹898 Cr₹493 Cr₹432 Cr₹885 Cr₹597 Cr₹561 Cr₹377 Cr₹410 Cr₹331 Cr₹355 Cr₹802 Cr₹563 Cr₹455 Cr
EBITDA₹155 Cr₹171 Cr₹627 Cr₹575 Cr₹516 Cr₹168 Cr₹822 Cr₹809 Cr₹484 Cr₹261 Cr₹444 Cr₹504 Cr₹327 Cr₹85 Cr₹74 Cr₹390 Cr₹-43 Cr₹96 Cr₹74 Cr₹93 Cr₹74 Cr₹84 Cr₹273 Cr₹162 Cr₹120 Cr
Net Profit₹268 Cr₹152 Cr₹518 Cr₹481 Cr₹407 Cr₹133 Cr₹677 Cr₹669 Cr₹386 Cr₹213 Cr₹369 Cr₹420 Cr₹276 Cr₹62 Cr₹57 Cr₹320 Cr₹-50 Cr₹80 Cr₹65 Cr₹75 Cr₹53 Cr₹63 Cr₹202 Cr₹123 Cr₹94 Cr
EPS14.968.4628.9426.8422.77.4337.8137.3221.5611.8820.623.2615.113.413.1117.55-2.774.43.574.112.93.4311.096.735.16
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹4,784 Cr₹4,127 Cr₹2,812 Cr₹2,044 Cr₹2,156 Cr₹2,022 Cr
EBITDA₹2,315 Cr₹1,693 Cr₹876 Cr₹220 Cr₹593 Cr₹590 Cr
Net Profit₹1,885 Cr₹1,388 Cr₹715 Cr₹170 Cr₹441 Cr₹461 Cr
EPS105.2677.3439.189.3224.225.26
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹8,631 Cr₹6,906 Cr₹5,657 Cr₹5,109 Cr₹4,792 Cr₹4,588 Cr
Total Liabilities₹1,019 Cr₹1,053 Cr₹784 Cr₹846 Cr₹669 Cr₹803 Cr
Equity₹7,612 Cr₹5,853 Cr₹4,874 Cr₹4,264 Cr₹4,123 Cr₹3,785 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹2,069 Cr₹1,498 Cr₹1,027 Cr₹95 Cr₹429 Cr₹525 Cr
Investing₹-1,414 Cr₹-1,033 Cr₹-477 Cr₹-5 Cr₹-103 Cr₹-167 Cr
Financing₹-211 Cr₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr₹-251 Cr
Free Cash Flow₹2,069 Cr₹1,498 Cr₹1,027 Cr₹95 Cr₹429 Cr₹525 Cr
Shareholding
Promoter 49.42% Institutions 22.83% Public 27.75%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search